From $399 billion in projected health expenditures to ministerial resignations and hospital strain, this week revealed both the scale and urgency of Canada’s healthcare transformation. Meanwhile, the U.S. shook up drug policy with a historic cannabis reclassification, and Canada’s tech sector capped the week on a high-growth note.
Canada’s Health Spending Soars as Reform Pressures and Equity Gaps Deepen
Canada’s healthcare bill is projected to hit $399 billion by 2025, according to the Canadian Institute for Health Information (CIHI), with public sector contributions continuing to dominate, making up 71% of total spending. Provinces like Nova Scotia and Newfoundland and Labrador are leading per capita expenditures, driven by aging populations and mounting system pressures. Meanwhile, policy changes such as the Canadian Dental Care Plan and early pharmacare agreements could reshape funding flows, with nearly six million Canadians approved for dental coverage as of late 2025.
But even as budgets grow, reform efforts are faltering. In a letter posted on social media, Christian Dubé, Minister of Health for Quebec, recently announced his resignation from both his ministerial role and the Coalition Avenir Québec (CAQ) party, citing frustration over the dilution of Bill 2, which he viewed as central to modernizing physician compensation and health system governance.
Dubé publicly acknowledged that the legislative process became overly confrontational and that the government ultimately chose to preserve existing governance arrangements rather than pursue the structural changes envisioned in Bill 2. He characterized the outcome as a missed opportunity to rebalance accountability in the health system and conceded that strategic and communication missteps contributed to the bill’s political fallout.
Tensions remain unresolved with the Fédération des médecins spécialistes du Québec (FMSQ), which continues to press for substantial salary increases to address interprovincial pay gaps and inequities affecting female-dominated specialties, highlighting the broader difficulty facing the Legault government in aligning compensation reform across physician groups while maintaining fiscal and political stability.
The resignation has been interpreted by critics as a setback for the government’s health reform agenda, while Premier François Legault acknowledged Dubé’s service in one of the province’s most politically demanding portfolios. The departure leaves the CAQ holding 80 of 125 seats, but with renewed uncertainty over the future direction of healthcare reform in Quebec.
Meanwhile, provinces are grappling with growing emergency capacity issues. British Columbia’s hospitals are operating beyond capacity as infrastructure has failed to keep pace with population growth and aging demographics, according to reporting by The Tyee. The province has roughly the same number of hospitals as in the early 1990s despite a sharply larger population, contributing to overcrowded emergency departments, hallway care, and prolonged waits for long-term care placements.
In Toronto, hospitals are increasingly looking to artificial intelligence to relieve pressure in emergency departments, Healthing.ca reports. Institutions such as SickKids are exploring AI tools to predict patient surges, reduce diagnostic delays, and streamline workflows, though experts note that meaningful impact will depend on sustained investment and system-wide integration.
Zooming in further, disability advocates say those most in need are still being left behind. The Wellesley Institute urges the federal government to strengthen disability-related supports in the 2025 budget, emphasizing expanded access to and adequacy of the Canada Disability Benefit to lift persons with disabilities out of poverty and help them thrive. The institute calls for making eligibility simpler for people already approved for other disability programs and increasing benefit levels over time to meaningfully improve quality of life.
At the same time, in a report by The Globe and Mail, many Canadian thalidomide survivors experience stressful, degrading processes when accessing medical support funds intended to assist with disability-related healthcare needs, pointing to administrative barriers in existing programs, while a Healthing.ca report shares that selecting a qualified disability lawyer can significantly impact a claimant’s ability to secure benefits or compensation, especially for complex injury or illness cases that affect long-term care and financial stability.
U.S. Drug Policy Shift: Cannabis Reclassified Under Trump
In a historic shift, U.S. President Donald Trump signed an executive order reclassifying marijuana and cannabidiol as Schedule III substances under the Controlled Substances Act. The move opens the door to medical research and broader clinical use, particularly for conditions like anorexia, pain management, and chemotherapy-related nausea. U.S.-based Trulieve Cannabis Corp. called the reclassification “long overdue,” marking a major milestone in American cannabis policy with potential implications for cross-border health regulations and trade.
Deloitte’s 2025 Tech Fast 50 Showcases Explosive Growth
This year, Deloitte has released the winners of the 2025 Technology Fast 50, where Canadian companies demonstrated remarkable scaling, with regeneration medicine firm Red Rock Regeneration Inc. achieving the highest four-year growth rate of 12,166% and a broad set of 50 companies making the list based on extraordinary revenue gains.
Want more of the latest news? Book a free consultation today to see how our Executive Daily Briefing can help you.
